Fang Peng

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Acute Coronary Syndrome

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Longhui Yan, Yan Zhou, Zhangjie Yu, Mengmei Xuan, Buyun Xu, Fang Peng
P2Y12 inhibitor pretreatment in patients with nonST-segment elevation acute coronary syndrome: A meta-analysis. Medicine 101 (27) (2022)
Zhaohai Zheng, Zhangjie Yu, Buyun Xu, Yan Zhou, Yangbo Xing, Qingsong Li, Weiliang Tang, Fang Peng
Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Liping Meng, Hui Lin, Xingxiao Huang, Jingfan Weng, Fang Peng, Shengjie Wu
METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA. Cell death & disease 13 (1) (2022)
Jingjing Zhao, Yan Zhou, Huahua Liu, Zhaohai Zheng, Shuqing Liu, Jiahao Peng, Hangyuan Guo, Weiliang Tang, Fang Peng
Effect of Musk Tongxin Dropping Pill on Myocardial Remodeling and Microcirculation Dysfunction in Diabetic Cardiomyopathy. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Jingjing Zhao, Huahua Liu, Buyun Xu, Jiahao Peng, Yangbo Xing, Weiliang Tang, Fang Peng
The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)